Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Manufacturing
(263/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
BioLineRx Ltd.
Mar 21, 2019
BioLineRx to Report Annual 2018 Results on March 28, 2019
Mar 14, 2019
BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference
Feb 12, 2019
Frost & Sullivan Publishes Immediate Report on BiolineRx
Feb 05, 2019
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
Feb 04, 2019
BioLineRx Announces Proposed Underwritten Public Offering of its American Depositary Shares and Warrants
Feb 04, 2019
BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
Jan 02, 2019
BioLineRx to Present at the 2019 Biotech Showcase
Dec 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
Dec 06, 2018
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York
Nov 20, 2018
BioLineRx Announces Receipt of FDA Biological Product Designation for Novel Cancer Immunotherapy Candidate AGI-134
Nov 01, 2018
BioLineRx to Report Third Quarter 2018 Results on November 8, 2018
Oct 20, 2018
BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
Oct 03, 2018
BioLineRx Increases Stake in BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications
Aug 30, 2018
BioLineRx to Present at 20th Annual Rodman & Renshaw Global Investment Conference in New York
Aug 13, 2018
BioLineRx Reports Second Quarter 2018 Financial Results
Aug 07, 2018
BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization
Aug 06, 2018
BioLineRx to Report Second Quarter 2018 Results on August 13, 2018
Aug 01, 2018
BioLineRx Initiates Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors
Jul 30, 2018
BioLineRx Announces Expansion of Immuno-Oncology Collaboration in Pancreatic Cancer
Jun 18, 2018
BioLineRx Presents New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients
‹‹
Page 3
››
Latest News
Apr 20, 2024
RMG Acquisition Corp. III Announces Cancellation of Dissolution
Apr 20, 2024
Bilateral Chamber Hosts Iraqi Prime Minister and his Delegation in Houston
Apr 20, 2024
Global Quantum Technology Market Research 2024-2029 with Assessment of Companies Focused on Quantum...
Apr 20, 2024
Eco Friendly Bottles Global Report 2024-2030: Edible Substitutes to Bottles Emerge as Potential Alternatives...
Apr 20, 2024
Global Needle Coke Market Analysis and Forecasts, 2023-2024 and 2033: Evolution in UHP Graphite Electrode...
Apr 20, 2024
Pure Spout Earns Industry Award for Best New Product
Apr 20, 2024
H2 Green Mining and Ohmium Sign Agreement to Boost Green Hydrogen in Chile
Apr 19, 2024
Churchill Serves as Sole Lead Arranger for a First Lien Credit Facility to Support Wynnchurch Capital’s...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events